Kris Kemp focuses on merger and acquisition transactions, securities offerings and representation of private equity and venture backed companies. In the last five years, Kris has been involved in more than $3 billion worth of M&A transactions. His corporate practice also includes providing capital structure advice to emerging and growth companies.
Whether his clients are start-up endeavors or publicly traded companies, Kris helps each business find a unique and strategic path for growth and works to identify and resolve potential issues. His practice includes:
Prior to joining Bass, Berry & Sims, Kris was a shareholder and the head of the corporate practice group of Harwell Howard Hyne Gabbert & Manner, P.C.
Tennessee Bar Association — Business Law Executive Council, Chair (2013-2016); Business Corporations Act Subcommittee (2011-2015)
Nashville Capital Network — Board of Directors
American Health Law Association (AHLA)
Representation of J. Knipper and Company, Inc. – one of the largest suppliers of end-to-end pharmaceutical samples management services and a Court Square portfolio company – and its affiliates, including KnippeRx, in its acquisition of Eagle Pharmacy – a Florida-based full-service, direct-to-patient (DTP) pharmacy. This strategic transaction for KnippeRx will expand the company’s pharmacy programs, scale and automation capabilities.
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of LogistiCare in its $80 million acquisition of National MedTrans, a single source Non-Emergency Medical Transportation (NEMT) benefit management company focused on delivering services to managed care organizations and governmental entities throughout the United States, as well as the extension of its revolving credit facilities from $200 million to $225 million
Representation of Lincare Holdings, Inc., a nationwide healthcare services organization and a Florida-based subsidiary of German multinational chemical company Linde AG, in its sale of their home infusion assets to KabaFusion, a provider of specialty acute and chronic home infusion therapies
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Representation of Lincare Holdings, Inc., a nationwide healthcare services organization and a Florida-based subsidiary of German multinational chemical company Linde AG, in its acquisition of Maverick Holdings II, Inc.
Represented Lincare Holdings Inc. in its acquisition of Specialized Medical Services from The Riverside Company
Represented Fred’s, Inc. in its sale of EntrustRx to CVS Health Corporation.
Represented Medical Specialties Distributors (MSD) to McKesson Corporation.
Represented Ebix, Inc. (NASDAQ: EBIX) in connection with the refinancing of its existing term loan and revolving credit facilities totaling $650 million
Chambers USA — Corporate/M&A (2013-2020)
Best Lawyers® — Nashville Securities/Capital Markets Law “Lawyer of the Year” (2020)
The Best Lawyers in America© — Mergers and Acquisitions Law; Securities/Capital Markets Law; Securities Regulation (2010-2021)
Martindale-Hubbell — AV Preeminent® Peer Review Rated
North Carolina State College of Humanities and Social Sciences — Distinguished Alumnus Award (2003)